JPY 1446.0
(-3.08%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 14.21 Billion JPY | -8.59% |
2022 | 14.55 Billion JPY | -0.54% |
2021 | 14.52 Billion JPY | 22.47% |
2020 | 11.67 Billion JPY | -2.8% |
2019 | 12.42 Billion JPY | 10.32% |
2018 | 11.37 Billion JPY | -14.87% |
2017 | 12.47 Billion JPY | 27.34% |
2016 | 10.81 Billion JPY | 4.8% |
2015 | 9.59 Billion JPY | 34.39% |
2014 | 7.12 Billion JPY | 50.04% |
2013 | 4.85 Billion JPY | -1.82% |
2012 | 4.99 Billion JPY | -0.87% |
2011 | 5.09 Billion JPY | 14.64% |
2010 | 4.14 Billion JPY | 34.84% |
2009 | 3.07 Billion JPY | 16.85% |
2008 | 2.72 Billion JPY | 39.2% |
2007 | 2.02 Billion JPY | 56.95% |
2006 | 1.28 Billion JPY | 21.54% |
2005 | 1.05 Billion JPY | 23.44% |
2004 | 860.78 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 4.25 Billion JPY | 0.73% |
2024 Q1 | 4.22 Billion JPY | 13.21% |
2023 Q2 | 1.76 Billion JPY | -10.29% |
2023 Q1 | 1.96 Billion JPY | -29.99% |
2023 Q4 | 3.96 Billion JPY | 13.33% |
2023 Q3 | 3.49 Billion JPY | 98.47% |
2023 FY | - JPY | -8.59% |
2022 Q2 | 2.43 Billion JPY | 36.63% |
2022 Q1 | 1.78 Billion JPY | -41.56% |
2022 FY | - JPY | -0.54% |
2022 Q4 | 2.8 Billion JPY | -4.66% |
2022 Q3 | 2.94 Billion JPY | 20.93% |
2021 Q4 | 3.04 Billion JPY | 8.05% |
2021 FY | - JPY | 22.47% |
2021 Q1 | 1.92 Billion JPY | -25.14% |
2021 Q2 | 2.4 Billion JPY | 25.09% |
2021 Q3 | 2.81 Billion JPY | 17.31% |
2020 Q1 | 627 Million JPY | -74.37% |
2020 Q4 | 2.56 Billion JPY | -7.86% |
2020 Q3 | 2.78 Billion JPY | 81.2% |
2020 Q2 | 1.53 Billion JPY | 145.14% |
2020 FY | - JPY | -2.8% |
2019 Q2 | 1.84 Billion JPY | 9.11% |
2019 FY | - JPY | 10.32% |
2019 Q1 | 1.69 Billion JPY | -19.45% |
2019 Q3 | 1.93 Billion JPY | 4.99% |
2019 Q4 | 2.44 Billion JPY | 26.34% |
2018 Q4 | 2.09 Billion JPY | 5.59% |
2018 Q3 | 1.98 Billion JPY | 23.49% |
2018 Q1 | 1.55 Billion JPY | -27.59% |
2018 FY | - JPY | -14.87% |
2018 Q2 | 1.6 Billion JPY | 3.74% |
2017 Q2 | 2.28 Billion JPY | 13.04% |
2017 FY | - JPY | 27.34% |
2017 Q1 | 2.02 Billion JPY | -11.49% |
2017 Q4 | 2.14 Billion JPY | -26.82% |
2017 Q3 | 2.92 Billion JPY | 27.87% |
2016 Q3 | 2.21 Billion JPY | 59.01% |
2016 Q4 | 2.28 Billion JPY | 3.3% |
2016 FY | - JPY | 4.8% |
2016 Q1 | 1.05 Billion JPY | -49.57% |
2016 Q2 | 1.39 Billion JPY | 32.04% |
2015 Q3 | 1.94 Billion JPY | 30.89% |
2015 Q2 | 1.48 Billion JPY | 14.13% |
2015 Q1 | 1.3 Billion JPY | 9.78% |
2015 Q4 | 2.09 Billion JPY | 7.56% |
2015 FY | - JPY | 34.39% |
2014 FY | - JPY | 50.04% |
2014 Q3 | 1.51 Billion JPY | 48.87% |
2014 Q4 | 1.18 Billion JPY | -21.51% |
2014 Q1 | 622 Million JPY | 176.44% |
2014 Q2 | 1.01 Billion JPY | 63.18% |
2013 Q2 | 397 Million JPY | -40.3% |
2013 Q3 | 927 Million JPY | 133.5% |
2013 Q4 | 225 Million JPY | -75.73% |
2013 FY | - JPY | -1.82% |
2013 Q1 | 665 Million JPY | -40.47% |
2012 Q4 | 1.11 Billion JPY | 4.3% |
2012 Q3 | 1.07 Billion JPY | 179.63% |
2012 Q2 | 383 Million JPY | 28.96% |
2012 FY | - JPY | -0.87% |
2012 Q1 | 297 Million JPY | -67.52% |
2011 Q4 | 914.43 Million JPY | 0.27% |
2011 Q1 | 733.3 Million JPY | -50.07% |
2011 FY | - JPY | 14.64% |
2011 Q2 | 732.68 Million JPY | -0.08% |
2011 Q3 | 911.94 Million JPY | 24.47% |
2010 Q4 | 1.46 Billion JPY | 15.14% |
2010 Q2 | 971.57 Million JPY | 33.19% |
2010 Q3 | 1.27 Billion JPY | 31.29% |
2010 Q1 | 729.47 Million JPY | -21.85% |
2010 FY | - JPY | 34.84% |
2009 Q2 | 619.59 Million JPY | 12.59% |
2009 Q1 | 550.29 Million JPY | -52.74% |
2009 FY | - JPY | 16.85% |
2009 Q4 | 933.44 Million JPY | -22.2% |
2009 Q3 | 1.19 Billion JPY | 93.64% |
2008 Q3 | 814.51 Million JPY | 162.45% |
2008 FY | - JPY | 39.2% |
2008 Q4 | 1.16 Billion JPY | 42.95% |
2008 Q2 | 310.34 Million JPY | 0.0% |
2007 FY | - JPY | 56.95% |
2006 FY | - JPY | 21.54% |
2005 FY | - JPY | 23.44% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
HEARTSEED INC | -1.44 Billion JPY | 1081.242% |
Cawachi Limited | 11.85 Billion JPY | -19.904% |
Pharmarise Holdings Corporation | 2.08 Billion JPY | -581.256% |
MatsukiyoCocokara & Co. | 98.01 Billion JPY | 85.502% |
Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 78.986% |
Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 41.634% |
NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 3.03% |
COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 72.366% |
Tsuruha Holdings Inc. | 67.2 Billion JPY | 78.855% |
Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -272.406% |
Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -424.004% |
Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 53.621% |
Medical System Network Co., Ltd. | 6.99 Billion JPY | -103.13% |
Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -239.327% |
Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 71.995% |
YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | -74.09% |
Astena Holdings Co., Ltd. | 4.17 Billion JPY | -240.61% |
Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 1.817% |
Ain Holdings Inc. | 31.22 Billion JPY | 54.484% |
Sundrug Co.,Ltd. | 56.23 Billion JPY | 74.731% |